Intellia Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intellia Therapeutics by Credit Suisse
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $4.1M | 134k | 30.49 |
2023-09-30 | $3.8M | 122k | 31.62 |
2023-06-30 | $5.1M | 125k | 40.78 |
2023-03-31 | $3.8M | 103k | 37.27 |
2022-12-31 | $3.2M | 93k | 34.89 |
2022-09-30 | $4.6M | 83k | 55.93 |
2022-06-30 | $4.3M | 84k | 51.77 |
2022-03-31 | $7.2M | 100k | 72.64 |
2021-12-31 | $8.4M | 71k | 118.23 |
2021-09-30 | $11M | 80k | 134.12 |
2021-06-30 | $17M | 102k | 162.00 |
2021-03-31 | $6.5M | 81k | 80.26 |
2020-12-31 | $5.6M | 102k | 54.28 |
2020-09-30 | $3.8M | 128k | 29.41 |
2020-06-30 | $2.3M | 108k | 21.00 |
2020-03-31 | $636k | 61k | 10.53 |
2019-12-31 | $596k | 41k | 14.66 |
2019-09-30 | $335k | 25k | 13.32 |
2019-06-30 | $428k | 26k | 16.33 |
2019-03-31 | $377k | 20k | 18.87 |
2018-12-31 | $362k | 27k | 13.60 |
2018-09-30 | $724k | 25k | 28.78 |
2018-06-30 | $967k | 35k | 27.37 |
2018-03-31 | $641k | 30k | 21.17 |
2017-12-31 | $498k | 26k | 19.24 |
2017-09-30 | $604k | 24k | 25.64 |
2016-12-31 | $163k | 12k | 13.16 |
2016-09-30 | $217k | 14k | 15.04 |